HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuo Uchiyama Selected Research

Reperfusion Injury

4/2019Lack of Cathepsin D in the Renal Proximal Tubular Cells Resulted in Increased Sensitivity against Renal Ischemia/Reperfusion Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuo Uchiyama Research Topics

Disease

10Neurodegenerative Diseases (Neurodegenerative Disease)
12/2023 - 06/2006
9Parkinson Disease (Parkinson's Disease)
06/2023 - 06/2004
8Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2022 - 06/2002
7Neoplasms (Cancer)
03/2015 - 10/2005
6Infections
12/2022 - 01/2005
5Inflammation (Inflammations)
12/2023 - 03/2007
5Hyperglycemia
01/2020 - 01/2010
5Lysosomal Storage Diseases (Lysosomal Storage Disease)
06/2015 - 12/2002
4Body Weight (Weight, Body)
01/2020 - 02/2009
4Brain Injuries (Brain Injury)
01/2016 - 01/2004
4Type 2 Diabetes Mellitus (MODY)
08/2014 - 01/2005
4Alzheimer Disease (Alzheimer's Disease)
07/2010 - 06/2004
3Ischemia
01/2016 - 01/2004
3Starvation
06/2006 - 01/2005
2Dementia (Dementias)
06/2023 - 11/2008
2Dehydration (Water Stress)
06/2023 - 01/2023
2Choroidal Neovascularization
03/2021 - 05/2010
2Chronic Pancreatitis
01/2021 - 11/2016
2Hypertrophy
01/2020 - 01/2011
2Hypertension (High Blood Pressure)
01/2020 - 12/2002
2Neuroblastoma
01/2020 - 04/2003
2Brain Edema (Cerebral Edema)
01/2018 - 01/2004
2Stroke (Strokes)
01/2018 - 02/2009
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 01/2004
2Infarction (Infarctions)
01/2018 - 04/2006
2Hepatitis
01/2017 - 12/2012
2Juvenile Amyotrophic Lateral Sclerosis 2
01/2016 - 03/2010
2Peptic Esophagitis (Reflux Esophagitis)
09/2014 - 05/2011
2Mitochondrial Diseases (Mitochondrial Disease)
09/2014 - 10/2012
2Parkinsonian Disorders (Parkinsonism)
05/2013 - 01/2007
2Gliosis
12/2012 - 04/2006
2Glucose Intolerance
11/2009 - 01/2005
2Atrophy
11/2008 - 02/2003
1Pneumococcal Infections
03/2024
1Fasciculation (Fasciculations)
12/2023
1Bites and Stings (Sting)
12/2023
1Melanoma (Melanoma, Malignant)
12/2023
1Synucleinopathies
06/2023
1Multiple System Atrophy
06/2023
1Skin Diseases (Skin Disease)
12/2022
1Proteostasis Deficiencies
01/2022
1Corneal Neovascularization
03/2021
1Severe Fever with Thrombocytopenia Syndrome
02/2021

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2002
11Cathepsin DIBA
01/2022 - 02/2003
6SynucleinsIBA
06/2023 - 11/2008
6Peptide Hydrolases (Proteases)FDA Link
01/2022 - 06/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2022 - 03/2007
3CeroidIBA
12/2023 - 02/2007
3EnzymesIBA
06/2015 - 06/2004
3Transcription Factors (Transcription Factor)IBA
01/2010 - 05/2002
2Osmium TetroxideIBA
06/2023 - 01/2023
2Cathepsin BIBA
01/2021 - 08/2010
2AntioxidantsIBA
01/2020 - 01/2016
2LeptinIBA
01/2020 - 11/2009
2Cysteine (L-Cysteine)FDA Link
01/2020 - 08/2010
2Leptin ReceptorsIBA
01/2020 - 01/2010
2InterferonsIBA
12/2018 - 12/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2018 - 01/2016
2LipofuscinIBA
12/2016 - 09/2007
2Kazal Pancreatic Trypsin InhibitorIBA
11/2016 - 01/2014
2Hyaluronic Acid (Hyaluronan)IBA
01/2016 - 05/2002
2DNA (Deoxyribonucleic Acid)IBA
03/2015 - 08/2003
2Mechanistic Target of Rapamycin Complex 1IBA
09/2014 - 01/2011
2CathepsinsIBA
09/2014 - 01/2009
2Glucose (Dextrose)FDA LinkGeneric
04/2014 - 01/2005
2Insulin (Novolin)FDA Link
04/2014 - 01/2011
2ResveratrolIBA
01/2013 - 10/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
12/2012 - 06/2006
2Indicators and Reagents (Reagents)IBA
05/2011 - 03/2007
2Cathepsin LIBA
05/2010 - 12/2002
2Retinaldehyde (Retinal)IBA
05/2010 - 02/2003
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2006 - 01/2004
2Amyloid beta-PeptidesIBA
10/2005 - 06/2004
2Amino AcidsFDA Link
05/2005 - 01/2005
1Streptococcus pneumoniae plY proteinIBA
03/2024
1PerforinIBA
03/2024
1CholesterolIBA
03/2024
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
12/2023
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2023
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
12/2023
1Octreotide (Sandostatin)FDA LinkGeneric
12/2023
1NF-kappa B (NF-kB)IBA
12/2023
1Biomarkers (Surrogate Marker)IBA
06/2023
1Fluorescent Dyes (Fluorescent Probes)IBA
06/2023
1Ethanol (Ethyl Alcohol)IBA
06/2023
1Glutaral (Glutaraldehyde)IBA
01/2023
1EPONIBA
01/2023
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2022
1Phenobarbital (Luminal)FDA Link
11/2022
1tau Proteins (tau Protein)IBA
01/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2022
1caffeic acidIBA
02/2021
1protocatechuic acidIBA
02/2021
13,4-Dihydroxyphenylacetic AcidIBA
02/2021
1catechol (pyrocatechol)IBA
02/2021

Therapy/Procedure

2Transplantation
03/2008 - 06/2004
1Immunotherapy
12/2023
1Lasers (Laser)
03/2021
1Sutures (Suture)
03/2021